DK0946546T3 - Pyridin-2-yl-methylaminderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som lægemidler - Google Patents
Pyridin-2-yl-methylaminderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som lægemidlerInfo
- Publication number
- DK0946546T3 DK0946546T3 DK97947107T DK97947107T DK0946546T3 DK 0946546 T3 DK0946546 T3 DK 0946546T3 DK 97947107 T DK97947107 T DK 97947107T DK 97947107 T DK97947107 T DK 97947107T DK 0946546 T3 DK0946546 T3 DK 0946546T3
- Authority
- DK
- Denmark
- Prior art keywords
- represents hydrogen
- methyl
- fluorine
- pct
- chlorine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614217A FR2755967B1 (fr) | 1996-11-21 | 1996-11-21 | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
| PCT/FR1997/002097 WO1998022459A1 (fr) | 1996-11-21 | 1997-11-20 | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0946546T3 true DK0946546T3 (da) | 2003-10-20 |
Family
ID=9497861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97947107T DK0946546T3 (da) | 1996-11-21 | 1997-11-20 | Pyridin-2-yl-methylaminderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som lægemidler |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6020345A (de) |
| EP (1) | EP0946546B1 (de) |
| JP (1) | JP4248605B2 (de) |
| CN (1) | CN1098263C (de) |
| AT (1) | ATE243691T1 (de) |
| AU (1) | AU732470B2 (de) |
| BR (1) | BR9713126B1 (de) |
| CA (1) | CA2272460C (de) |
| DE (1) | DE69723104T2 (de) |
| DK (1) | DK0946546T3 (de) |
| ES (1) | ES2202647T3 (de) |
| FR (1) | FR2755967B1 (de) |
| PT (1) | PT946546E (de) |
| WO (1) | WO1998022459A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US20080300281A1 (en) * | 1997-12-22 | 2008-12-04 | Jacques Dumas | Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas |
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| US20080269265A1 (en) * | 1998-12-22 | 2008-10-30 | Scott Miller | Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas |
| US7351834B1 (en) * | 1999-01-13 | 2008-04-01 | Bayer Pharmaceuticals Corporation | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| JP2002534468A (ja) * | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
| EP1140840B1 (de) | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren |
| US8124630B2 (en) * | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| FR2820743B1 (fr) * | 2001-02-09 | 2005-02-25 | Pf Medicament | Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine |
| US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| DE10129320A1 (de) * | 2001-06-19 | 2003-04-10 | Norbert Mueller | Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen |
| US20060167074A1 (en) * | 2001-06-19 | 2006-07-27 | Norbert Muller | Methods and compositions for the treatment of psychiatric disorders |
| FR2827172B1 (fr) * | 2001-07-13 | 2004-07-02 | Pf Medicament | Derives de pyridin-2-yl-methylamine pour le traitement de la dependance aux opioides |
| US8106074B2 (en) * | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
| ES2393900T3 (es) * | 2001-12-03 | 2012-12-28 | Bayer Healthcare Llc | Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos |
| US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
| WO2003068229A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| EP2324825A1 (de) * | 2002-02-11 | 2011-05-25 | Bayer Healthcare LLC | Arylharnstoffe mit Angiogenese hemmender Aktivität |
| PT1580188E (pt) * | 2002-02-11 | 2012-01-25 | Bayer Healthcare Llc | Aril-ureias como inibidores de cinases |
| US20040023961A1 (en) * | 2002-02-11 | 2004-02-05 | Bayer Corporation | Aryl ureas with raf kinase and angiogenisis inhibiting activity |
| KR100435105B1 (ko) * | 2002-04-17 | 2004-06-09 | 금호석유화학 주식회사 | 카르복시이미데이트 리간드에 기초한 원자이동 라디칼중합을 이용한 새로운 메틸메타아크릴레이트의 중합방법 |
| FR2840900B1 (fr) * | 2002-06-18 | 2005-02-25 | Pf Medicament | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| FR2852244B1 (fr) * | 2003-03-13 | 2007-09-07 | Pf Medicament | Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene |
| ATE366108T1 (de) * | 2003-05-20 | 2007-07-15 | Bayer Pharmaceuticals Corp | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
| NZ580384A (en) * | 2003-07-23 | 2011-03-31 | Bayer Pharmaceuticals Corp | 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions |
| FR2891274B1 (fr) * | 2005-09-27 | 2007-11-23 | Pierre Fabre Medicament Sa | Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires. |
| EP2058306A1 (de) * | 2007-11-08 | 2009-05-13 | Schwarz Pharma Ag | Heteroaryl-substituierte 2-Pyridinylmethylaminderivate |
| WO2012145617A2 (en) * | 2011-04-22 | 2012-10-26 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
| HUE037945T2 (hu) | 2014-07-09 | 2018-09-28 | Pf Medicament | Eljárás mozgási rendellenességek kezelésére befiradollal |
| EP3260452A1 (de) | 2016-06-24 | 2017-12-27 | Neurolixis | Verbindungen zur behandlung von serotoninsensitiven erkrankungen gesteuert durch 5-ht1a rezeptoren |
| WO2018057576A1 (en) | 2016-09-22 | 2018-03-29 | Auspex Pharmaceuticals, Inc. | Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds |
| EP3664787B1 (de) | 2017-07-20 | 2022-07-20 | Neurolixis | Verwendung von selektiven serotin-5-ht1a-rezeptor-agonisten zur behandlung von nebenwirkungen von vmat-inhibitoren |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| EP0661266A1 (de) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituierte cyclische Aminverbindungen als 5HT2 Antagonisten |
-
1996
- 1996-11-21 FR FR9614217A patent/FR2755967B1/fr not_active Expired - Lifetime
-
1997
- 1997-11-20 WO PCT/FR1997/002097 patent/WO1998022459A1/fr active IP Right Grant
- 1997-11-20 DK DK97947107T patent/DK0946546T3/da active
- 1997-11-20 CN CN97181172A patent/CN1098263C/zh not_active Expired - Lifetime
- 1997-11-20 EP EP97947107A patent/EP0946546B1/de not_active Expired - Lifetime
- 1997-11-20 JP JP52329298A patent/JP4248605B2/ja not_active Expired - Lifetime
- 1997-11-20 AT AT97947107T patent/ATE243691T1/de active
- 1997-11-20 BR BRPI9713126-1A patent/BR9713126B1/pt not_active IP Right Cessation
- 1997-11-20 PT PT97947107T patent/PT946546E/pt unknown
- 1997-11-20 DE DE69723104T patent/DE69723104T2/de not_active Expired - Lifetime
- 1997-11-20 US US09/308,613 patent/US6020345A/en not_active Expired - Lifetime
- 1997-11-20 AU AU52276/98A patent/AU732470B2/en not_active Expired
- 1997-11-20 CA CA002272460A patent/CA2272460C/fr not_active Expired - Lifetime
- 1997-11-20 ES ES97947107T patent/ES2202647T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6020345A (en) | 2000-02-01 |
| PT946546E (pt) | 2003-11-28 |
| CA2272460C (fr) | 2009-11-17 |
| CN1098263C (zh) | 2003-01-08 |
| WO1998022459A1 (fr) | 1998-05-28 |
| BR9713126B1 (pt) | 2009-01-13 |
| DE69723104D1 (de) | 2003-07-31 |
| BR9713126A (pt) | 2000-04-11 |
| AU5227698A (en) | 1998-06-10 |
| CN1242772A (zh) | 2000-01-26 |
| FR2755967B1 (fr) | 1999-01-29 |
| AU732470B2 (en) | 2001-04-26 |
| ATE243691T1 (de) | 2003-07-15 |
| EP0946546A1 (de) | 1999-10-06 |
| ES2202647T3 (es) | 2004-04-01 |
| DE69723104T2 (de) | 2004-04-29 |
| EP0946546B1 (de) | 2003-06-25 |
| JP2001504129A (ja) | 2001-03-27 |
| JP4248605B2 (ja) | 2009-04-02 |
| FR2755967A1 (fr) | 1998-05-22 |
| CA2272460A1 (fr) | 1998-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0946546T3 (da) | Pyridin-2-yl-methylaminderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som lægemidler | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| NO20051225L (no) | 1,2,4- oksadiazoler som modulatorer av metabotropisk glutamat-reseptor-5 | |
| HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
| NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO992878D0 (no) | Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas°ytiske blandinger som inneholder dem | |
| BR9908332A (pt) | Derivados de n-[carbonil(anel di ou triaza diinsaturado de cinco membros substituìdo)] derivados de guanidina para tratamento de esquemia | |
| NO20052493L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| DK0695301T3 (da) | Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne | |
| NO20033732L (no) | N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser. | |
| ATE394383T1 (de) | Biphenylkarbonsäureamidderivate als p38 kinase- inhibitoren | |
| DK0773943T3 (da) | Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| DK0589995T3 (da) | Hidtil ukendte polypeptider og deres anvendelse | |
| NO984414L (no) | Nye 5-ring-heterocykler, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse | |
| DK0891341T3 (da) | 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider | |
| DK0888341T3 (da) | Hidtil ukendte svovlderivater indeholdende en amidbinding, fremgangsmåde for fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse | |
| MXPA06001039A (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
| ATE172454T1 (de) | Pyridazinon derivate mit pharmazeutischer wirkung | |
| ATE189894T1 (de) | Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel | |
| DK0880496T3 (da) | Biphenylforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
| NO992870D0 (no) | Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem | |
| DK0566666T3 (da) | Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler | |
| DK0776325T3 (da) | Ny anvendelse af og nye imidazolderivater, fremgangsmåde til deres fremstilling, nye mellemprodukter deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf |